Fingerprint Dive into the research topics of 'The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD)'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD)
Amber Afzal, Maryna Tarbunova, George Despotis, Brenda J. Grossman
Research output: Contribution to journal › Article › peer-review